Rosemary Crane

Rosemary Crane

Director/Board Member chez CERTARA, INC.

Fortune : 2 M $ au 31/03/2024

64 ans
Health Technology
Consumer Services
Finance

Profil

Rosemary A.
Crane
currently works at Teva Pharmaceutical Industries Ltd., as Independent Director from 2015, HMH Hospitals Corp, Inc., as Director-Discovery & Innovation, Catalent Pharma Solutions, Inc., as Director from 2018, Tarsus Pharmaceuticals, Inc., as Independent Director from 2021, Certara, Inc., as Independent Director from 2022, Hackensack Meridian Health Center For Discovery & Innovation, as Director, and The State University of New York, as Member-Foundation Board.
Ms. Crane also formerly worked at Epocrates LLC, as President, Chief Executive Officer & Director in 2011, STRATA Skin Sciences, Inc., as President, Chief Executive Officer & Director in 2014, Epocrates, Inc. (Research), as President & Chief Executive Officer in 2011, MELA Sciences Inc., as President & Chief Executive Officer from 2013 to 2014, Johnson & Johnson, as Group Chairman-OTC & Nutritional Group from 2006 to 2008, Zealand Pharma A, as Vice Chairman from 2015 to 2019, Cipher Pharmaceuticals, Inc., as Director in 2016, Targanta Therapeutics Corp., as Director from 2008 to 2009, Edge Therapeutics, Inc., as Independent Director from 2017 to 2019, Unilife Corp., as Independent Director from 2016 to 2017, Unilife Medical Solutions, Inc., as Director, Catalent, Inc., as Independent Director from 2018 to 2024, Bristol Myers Squibb Co., as President-US Primary Care Division from 2000 to 2002, and Apple Tree venture Managemnet Llc, as Partner in 2013.
Ms. Crane received her undergraduate degree in 1981 from State University of New York College at Oswego and Masters Business Admin degree in 1986 from Kent State University (Ohio).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/08/2023 82 507 ( 0,01% ) 1 M $ 31/03/2024
04/12/2023 16 880 ( 0,01% ) 952 876 $ 31/03/2024
23/05/2023 9 324 ( 0,01% ) 166 713 $ 31/03/2024
22/06/2023 2 000 ( 0,01% ) 72 700 $ 31/03/2024

Postes actifs de Rosemary Crane

SociétésPosteDébut
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Director/Board Member 01/09/2015
TARSUS PHARMACEUTICALS, INC. Director/Board Member 11/08/2021
CERTARA, INC. Director/Board Member 21/07/2022
The State University of New York Corporate Officer/Principal -
Hackensack Meridian Health Center For Discovery & Innovation Director/Board Member -
Director/Board Member 01/03/2018
Corporate Officer/Principal -
Tous les postes actifs de Rosemary Crane

Anciens postes connus de Rosemary Crane

SociétésPosteFin
CATALENT, INC. Director/Board Member 25/01/2024
ZEALAND PHARMA A/S Director/Board Member 04/04/2019
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Rosemary Crane

Formation de Rosemary Crane

State University of New York College at Oswego Undergraduate Degree
Kent State University (Ohio) Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Rosemary Crane

Relations

99

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées9
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

JOHNSON & JOHNSON

Health Technology

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

CIPHER PHARMACEUTICALS INC.

Health Technology

STRATA SKIN SCIENCES, INC.

Health Technology

ZEALAND PHARMA A/S

Health Technology

CATALENT, INC.

Health Technology

TARSUS PHARMACEUTICALS, INC.

Health Technology

CERTARA, INC.

Technology Services

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Electronic Technology

Finance

Health Technology

Finance

Hackensack Meridian Health Center For Discovery & Innovation

MELA Sciences Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Rosemary Crane